Summary Slide.png (70.77 kB)

Healthcare Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis – a Retrospective Study

media

posted on 2020-07-03, 15:07 authored by Johan Dalén, Karin Luttropp, Axel Svedbom, Christopher M. Black, Sumesh Kachroo

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

References

https://link.springer.com/article/10.1007/s12325-020-01425-8

Usage metrics

Read the peer-reviewed publication

Advances in Therapy

Keywords

Ankylosing spondylitis Biologics Cost Inflammatory Arthritis Psoriatic arthritis Rheumatoid arthritis Rheumatology Subcutaneous TNF-α inhibitors Switching Treatment persistence

Licence

CC BY-NC 4.0